Clinical-Scale Isolation of Interleukin-2-Stimulated Liver Natural Killer Cells for Treatment of Liver Transplantation with Hepatocellular Carcinoma
Tumor recurrence is the main limitation of liver transplantation (LT) in patients with hepatocellular carcinoma (HCC) and can be promoted by immunosuppressants. However, there is no prevention or treatment for HCC recurrence after LT. Here we describe a clinical-scale method for an adoptive immunoth...
Main Authors: | Masahiro Ohira, Seigo Nishida M.D., Ph.D., Panagiotis Tryphonopoulos, Akin Tekin, Gennaro Selvaggi, Jang Moon, David Levi, Camillo Ricordi, Kohei Ishiyama, Yuka Tanaka, Hideki Ohdan, Andreas G. Tzakis |
---|---|
Format: | Article |
Language: | English |
Published: |
SAGE Publishing
2012-07-01
|
Series: | Cell Transplantation |
Online Access: | https://doi.org/10.3727/096368911X627589 |
Similar Items
-
CD52-Negative NK Cells Are Abundant in the Liver and Less Susceptible to Alemtuzumab Treatment.
by: Ryuichi Hotta, et al.
Published: (2016-01-01) -
Essential updates 2018/2019: Liver transplantation
by: Masahiro Ohira, et al.
Published: (2020-05-01) -
Hepatic irradiation persistently eliminates liver resident NK cells.
by: Ryosuke Nakano, et al.
Published: (2018-01-01) -
Propylthiouracil-Induced Acute Liver Failure: Role of Liver Transplantation
by: Andres F. Carrion, et al.
Published: (2010-01-01) -
Hepatectomy leads to loss of TRAIL-expressing liver NK cells via downregulation of the CXCL9-CXCR3 axis in mice.
by: Takuya Yano, et al.
Published: (2017-01-01)